Krishna Institute of Medical Sciences Ltd - Stock Valuation and Financial Performance

BSE: 543308 | NSE: KIMS | Hospital & Healthcare Services | Small Cap

Krishna Inst.Medi Share Price

535.30 -6.90 -1.27%
as on 21-Feb'25 16:59

DeciZen - make an informed investing decision on Krishna Inst.Medi

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Krishna Institute of Medical Sciences stock performance -

P/E Ratio (SA):
83.15
Market Cap:
21,419.4 Cr.
52-wk low:
350
52-wk high:
674

Is Krishna Institute of Medical Sciences Ltd an attractive stock to invest in?

1. Is Krishna Institute of Medical Sciences Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Krishna Institute of Medical Sciences Ltd is a good quality company.

2. Is Krishna Institute of Medical Sciences Ltd undervalued or overvalued?

The key valuation ratios of Krishna Institute of Medical Sciences Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Krishna Institute of Medical Sciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Krishna Institute of Medical Sciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Krishna Inst.Medi:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Krishna Institute of Medical Sciences Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE %
9.5%14.6%4.8%6.4%3.9%22.7%29.6%31.2%22.6%17%-
Value Creation
Index
-0.20.3NANA-0.71.01.61.30.70.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales
3944855366287077909331,1431,1321,2221,343
Sales YoY Gr.
-23.1%10.5%17.3%12.5%11.8%18.1%22.6%-1%8%-
Adj EPS
0.20.7-2.9-3.2-1.23.34.976.35.96.4
YoY Gr.
-263.2%-515.9%NANANA49.7%43.4%-9.9%-6.8%-
BVPS (₹)
6.77.4-4.8-7.913.516.823.434.440.846.651.8
Adj Net
Profit
6.924.3-72-81.3-43.6121189280253235258
Cash Flow from Ops.
56.789.479.794.2109161291284271262-
Debt/CF from Ops.
4.92.87.97.11.71.10.40.101.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 13.4%11.6%9.4%8%
Adj EPS 46.4%NA6.4%-6.8%
BVPS24%28.1%25.9%14.4%
Share Price - - 29.9% 21%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
3.29.7-101.951-28.621.524.724.516.813.513.1
Op. Profit
Mgn %
18.921.610.410.38.126.133.13532.129.929.3
Net Profit
Mgn %
1.75-13.4-12.9-6.215.420.324.522.319.319.2
Debt to
Equity
1.21-5.2-3.30.40.30.1000.2-
Working Cap
Days
8986919297886664909939
Cash Conv.
Cycle
39-13-2648-11-6-73155

Recent Performance Summary

Sales growth is good in last 4 quarters at 10.85%

Return on Equity has declined versus last 3 years average to 13.10%

Sales growth has been subdued in last 3 years 9.43%

Net Profit has been subdued in last 3 years 6.41%

Latest Financials - Krishna Institute of Medical Sciences Ltd

Standalone Consolidated
TTM EPS (₹) 6.4 8.7
TTM Sales (₹ Cr.) 1,343 2,872
BVPS (₹.) 51.8 52.3
Reserves (₹ Cr.) 1,994 2,015
P/BV 10.33 10.23
PE 83.15 61.52
From the Market
52 Week Low / High (₹) 350.02 / 674.00
All Time Low / High (₹) 187.61 / 674.00
Market Cap (₹ Cr.) 21,419
Equity (₹ Cr.) 80
Face Value (₹) 2
Industry PE 38.9

Quarterly Results

 Jun'23 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %
Sales (₹ Cr.) 18.3 N/A21.6 17.7
Adj EPS (₹) 1 N/A0.6 -36.5
Op. Profit Mgn % 13.38 N/A7.16 -622 bps
Net Profit Mgn % 7.06 N/A3.83 -323 bps

Management X-Ray of Krishna Inst.Medi:

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:38.82%Institutions:47.73%Non-Institutions:13.45%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep22Dec22Mar23Jun23Sep23Dec23Mar24Jun24Sep24Dec240%10%20%30%40%
Pledged *19.3919.3918.1015.5316.1616.1016.1015.7815.3512.13
* Pledged shares as % of Promoter's holding (%)

Valuation of Krishna Inst.Medi

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Krishna Inst.Medi

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Narayana Hrudayalay 1,399.2 -5 (-0.4%) Small Cap 5,018 38.4 15.7 36.6 8.4
Aster DM Healthcare 414.8 -3.2 (-0.8%) Small Cap 3,699 105.6 5.5 4 6
Dr. Lal Pathlabs 2,597.6 -29.2 (-1.1%) Small Cap 1,967 55.3 19.5 47.5 10
Indraprastha Medical 396.3 -13.7 (-3.3%) Small Cap 1,245 16.5 10 24.9 6.7
RainbowChildrenS Med 1,320 19.3 (1.5%) Small Cap 1,237 23 17.4 56.6 9.2
Krishna Inst.Medi 535.3 -6.9 (-1.3%) Small Cap 1,222 6.4 19.3 84.2 10.5
Kovai Medical Center 6,132.6 6.1 (0.1%) Small Cap 1,220 188.7 14.8 32.5 6.5
Metropolis Health. 1,653.7 -22.6 (-1.4%) Small Cap 1,208 29.7 11 56.5 7.1
HealthcareGlobal 500 -8.4 (-1.6%) Small Cap 1,099 -0.8 3 - 6
Jupiter Life Line 1,487.4 -1.9 (-0.1%) Small Cap 911 28 16.7 53.2 7.1
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales3944855366287077909331,1431,1321,222
Operating Expenses 321380480564650584625745769857
Manufacturing Costs1311544119820349243281285334
Material Costs104119130152167180201250238251
Employee Cost 667692115127137147174187220
Other Costs 21312179915421834405952
Operating Profit 73105566557206308398363366
Operating Profit Margin (%) 18.6%21.6%10.4%10.3%8.1%26.1%33.0%34.8%32.1%29.9%
Other Income 44346710272418
Interest 34367988362418957
Depreciation 31343538414345454558
Exceptional Items 0000000000
Profit Before Tax 1238-55-57-13147254371337318
Tax 6141724302566938583
Profit After Tax 624-72-81-44121189278252235
PAT Margin (%) 1.5%5.0%-13.4%-12.9%-6.2%15.3%20.2%24.3%22.3%19.3%
Adjusted EPS (₹)0.20.7-2.9-3.2-1.23.34.97.06.35.9
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 237261-120-1995046249071,3781,6311,866
Share Capital 9705050747478808080
Reserves 228191-170-2494295498301,2981,5511,786
Minority Interest0000000000
Debt22918820824116114911840322
Long Term Debt1981731982141521476840257
Short Term Debt3215102792500065
Trade Payables58637479747885817378
Others Liabilities 114134581669119106103106108130
Total Liabilities 6386467437898579571,2141,5691,8122,397

Fixed Assets

Gross Block6246575396486807127758278891,008
Accumulated Depreciation1301593572113153193235277334
Net Fixed Assets494498504576567559582592612674
CWIP 1026400281316292
Investments 15182331801782135428261,062
Inventories10111516192216261922
Trade Receivables35627696100997387120149
Cash Equivalents 137898392501804020
Others Assets61485361835871128178177
Total Assets 6386467437898579571,2141,5691,8122,397

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 57898094109161291284271262
PBT 1238-55-57-13147254371337318
Adjustment 65691721881776255262548
Changes in Working Capital -8-19-26-16-29-125-17-17-18
Tax Paid -121-11-22-25-47-43-96-75-85
Cash Flow From Investing Activity -64-39-100-52-99-108-317-375-238-569
Capex -72-33-100-45-46-21-72-69-121-320
Net Investments 16-30000-21256118-18
Others -8-30-7-53-87-33-362-235-230
Cash Flow From Financing Activity 11-6125-42-12-242576-15289
Net Proceeds from Shares 3703108809519200
Net Proceeds from Borrowing 0089-29-143-35-102-60-14257
Interest Paid -35-34-31-28-21-19-14-4-1-4
Dividend Paid 0000000000
Others 9-26-6316633046-51036
Net Cash Flow 4-1050-2280-1518-18
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)2.689.76N/AN/A-28.6721.4824.6424.3716.7913.46
ROCE (%)9.4614.56N/AN/A3.922.7229.5731.2422.5817.02
Asset Turnover Ratio0.630.760.770.820.860.870.860.820.670.58
PAT to CFO Conversion(x)9.53.71N/AN/AN/A1.331.541.021.081.11
Working Capital Days
Receivable Days30364750514634263340
Inventory Days9899997776
Payable Days203186191183167154148121118110

Krishna Institute of Medical Sciences Ltd Stock News

Krishna Institute of Medical Sciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Krishna Inst.Medi on 21-Feb-2025 16:59 is ₹535.3.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Feb-2025 16:59 the market cap of Krishna Inst.Medi stood at ₹21,419.4.
The latest P/E ratio of Krishna Inst.Medi as of 21-Feb-2025 16:59 is 83.15.
The latest P/B ratio of Krishna Inst.Medi as of 21-Feb-2025 16:59 is 10.33.
The 52-week high of Krishna Inst.Medi is ₹674.0 and the 52-week low is ₹350.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Krishna Inst.Medi is ₹1,343 ( Cr.) .

About Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences is one of the largest corporate healthcare groups in AP and Telangana in terms of number of patients treated and treatments offered. It also provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care in Tier 2-3 cities and primary, secondary, tertiary and quaternary healthcare in Tier 1 cities. It operates multi-specialty hospitals under the “KIMS Hospitals” brand. It also offers a comprehensive range of healthcare services across specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother & child care.

The company strives to provide quality service to more patients, and it has scope for additional patients and improved occupancy rates. It strategically focuses on the southern India healthcare market where it has a strong understanding of regional nuances, customer culture and the mindset of medical professionals and where there is significant and growing need for quality and affordable healthcare services. Each of its hospitals also has integrated diagnostic services and pharmacies that cater to its patients. Affordability and quality of healthcare services provided by it and its track record of building long-term relationships with medical professionals including its doctors, has enabled growth and helped it build its ‘KIMS Hospitals’ brand. It operates and manages all of its hospitals, which provides it with greater control over its facilities and helps it to better deliver high quality and affordable healthcare services.

Business area of the company

The company offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.

Awards and Accreditations

  • 2008: KIMS Secunderabad received its first ISO 9001-2008 certification from AQA International LLC.
  • 2011: KIMS Secunderabad received its first accreditation from NABH.
  • 2015: KIMS Secunderabad was awarded the ‘Healthcare Excellence Award’ by the Indo Global Healthcare Summit and Expo.
  • 2015: KIMS Secunderabad was awarded ‘Nursing Excellence’ award by AHPI.
  • 2015: KIMS Secunderabad was accredited with ISO 9001:2015 certification.
  • 2017: KIMS Secunderabad was awarded by AHPI as a ‘Patient Friendly Hospital’.
  • 2017: KIMS Secunderabad became laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 2015-2016.
  • 2017: KIMS Secunderabad was awarded ‘Best Hospital of the Year’ in the multispecialty hospital category in Hyderabad and eight other specialities by Times Healthcare Achievers Awards.
  • 2019: 2019 KIMS Secunderabad received certificate of excellence in the category of ‘Best Super-Speciality Hospital in Telangana’ at the National Quality Excellence Awards, 2019 hosted by Praxis Media Institute.
  • 2019: KIMS Secunderabad was awarded ‘Best Hospital to Work For’ from AHPI Global Conclave.
  • 2019: KIMS Secunderabad was accredited by NABL.
  • 2019: KIMS Nellore was issued a certificate of accreditation by NABH for being compliant with NABH pre-accreditation entry level hospital requirements.
  • 2020: KIMS Secunderabad ranked the third best hospital in Hyderabad by The Week magazine.
  • 2020: KIMS Kondapur was accredited with a certificate of assessment for exhibition of its intent and commitment towards ensuring safety and hygiene at workplace by IRClass Systems and Solutions.
  • 2021: The cardiology, emergency and trauma, nephrology and neuroscience departments of KIMS Hyderabad were ranked first in the Hyderabad Multi Speciality category in the Times of India, Hyderabad, All India Critical Care Hospital Ranking Survey, 2021.
  • 2021: The emergency and trauma and nephrology departments of KIMS Hyderabad were ranked second in the South Multi Speciality Category in the Times of India, Hyderabad, All India Critical Care Hospital Ranking Survey, 2021.

Major events and milestones

  • 2000: KIMS Nellore established by BRMH. The business division of BRMH, including the hospital, was transferred to our Company pursuant to the 2012 Scheme.
  • 2004: KIMS Secunderabad established by Company.
  • 2010: Investment by Milestone Private Equity Fund (“MPEF”) in Company.
  • 2014: Acquisition of 57.83% of the equity shareholding of Arunodaya Hospitals.
  • 2015: Investment by India Advantage Fund (IAF) and Emerging India Fund (EIF) and exit of MPEF from our Company pursuant to the share purchase agreement dated June 23, 2014 entered into between, amongst others, IAF, EIF and MPEF.
  • 2017: Acquisition of KIMS Ongole by way of slump sale agreement.
  • 2019: Acquisition of 51% of the equity shareholding of ICIMSPL.
  • 2019: Acquisition of 80% of the equity shareholding of SIMSPL.
  • 2019: Investment by General Atlantic in our Company and exit of IAF and EIF from our Company pursuant to the share purchase agreement dated June 14, 2018 entered into between, amongst others, General Atlantic, IAF and EIF.
  • 2020: Acquisition of 55% of the equity shareholding of KHKPL.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on